Re: Schaub et al.: Intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy: results from a randomized clinical trial (Ophthalmology. 2022;129:1129e1141)

Koen A van Overdam, Jerry Sebag

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalOphthalmology
Publication statusPublished - Apr 2023

Cite this